ARCHIVES

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

This article is from The Cancer Letter archive.

Vol. 22 No. 45 | November 22, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973

In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing

November 16, 1979

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991